NCT00116714已完成不适用
Rheumatoid Arthritis Disease Modifying Anti-Rheumatic Drug (DMARD) Intervention and Utilization Study (RADIUS 1)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 4,968
研究概览
简要总结
The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to systematically collect and document use patterns, effectiveness, and safety of DMARD treatments currently used in the management of rheumatoid arthritis (RA). It is anticipated that study data may help improve the quality of information upon which clinical decisions are based.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Fulfillment of the 1987 American Rheumatism Association criteria for RA
- •Currently requiring a new DMARD (change or addition)
排除标准
- •Currently enrolled in a clinical trial with treatments or patient visits imposed by a protocol
- •Nursing or pregnant women
- •Patients with active infection
研究组 & 干预措施
Observation
干预措施: DMARD (Drug)
研究者
相似试验
已完成
不适用
Rheumatoid Arthritis DMARD Intervention and UtilizationStudyRheumatoid ArthritisNCT00116727Amgen5,103
已完成
4 期
Assessing Withdrawal of Disease-Modifying Antirheumatic Drugs in Rheumatoid ArthritisRheumatoid ArthritisNCT01881308Diakonhjemmet Hospital320
招募中
3 期
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRheumatoid ArthritisNCT03414502University of Nebraska400
已完成
4 期
Objective Study in Rheumatoid ArthritisArthritis, RheumatoidNCT00451971Sanofi249
已完成
4 期
Efficacy of HUMIRA in Subjects With Active Rheumatoid ArthritisRheumatoid ArthritisNCT00234897Abbott1,938